Savannah Partridge

30PUBLICATIONS
155CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 24, 2026
Automated Apparent Diffusion Coefficient Measurement of Breast Tumors in Diffusion-weighted MRI for Early Neoadjuvant Chemotherapy Response Assessment.

|Jun 25, 2026
Image Quality Assessment of Diffusion-Weighted Imaging (DWI) and Its Impact on Apparent Diffusion Coefficient (ADC) as a Quantitative Imaging Biomarker for Predicting Response to Neoadjuvant Chemotherapy in High-Risk Early Breast Cancer.

|Jun 12, 2026
Deep Learning-Based Synthetic Contrast-Enhanced Breast MRI for Monitoring Response to Neoadjuvant Therapy.

|Dec 11, 2025
Multiparametric MRI Markers Associated with Breast Cancer Risk in Women with Dense Breasts.

Wesley Surento, Romy Fischer, Debosmita Biswas

|Nov 27, 2025
Exploratory Analysis of the Impact of a Single Dose of Trastuzumab on the Immune Microenvironment in HER2-Positive Early-Stage Breast Cancer.

Nikita Bastin, Jessica Mezzanotte-Sharpe, Rebecca Alvarez

|Aug 07, 2025
Can we cut the contrast? DWI shows similar value to standard MRI for assessing treatment response in breast cancer.

Patrick J Bolan, Habib Rahbar, Savannah C Partridge

Pageof 5

Frequent Collaborators

9 joint publications

Habib Rahbar

8 joint publications

Anum S Kazerouni

7 joint publications

Daniel S Hippe

6 joint publications

Debosmita Biswas